The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial
Open accessAbstract
Importance: Indwelling pleural catheter and talc pleurodesis are established treatments for malignant pleural effusions among patients with poor prognosis. Objective: To determine whether indwelling pleural catheters are more effective than talc pleurodesis in reducing total hospitalization days in the remaining lifespan of patients with malignant pleural effusion. Design, Setting, and Participants: This open-label, randomized clinical trial included participants recruited from 9 centers in Australia, New Zealand, Singapore, and Hong Kong between July 2012 and October 2014; they were followed up for 12 months (study end date: October 16, 2015). Patients (n = 146) with symptomatic malignant pleural effusion who had not undergone indwelling pleural catheter or pleurodesis treatment were included. Interventions: Participants were randomized (1:1) to indwelling pleural catheter (n = 74) or talc pleurodesis (n = 72), minimized by malignancy (mesothelioma vs others) and trapped lung (vs not), and stratified by region (Australia vs Asia). Main Outcomes and Measures: The primary end point was the total number of days spent in hospital from procedure to death or to 12 months. Secondary outcomes included further pleural interventions, patient-reported breathlessness, quality-of-life measures, and adverse events. Results: Among the 146 patients who were randomized (median age, 70.5 years; 56.2% male), 2 withdrew before receiving the randomized intervention and were excluded. The indwelling pleural catheter group spent significantly fewer days in hospital than the pleurodesis group (median, 10.0 [interquartile range [IQR], 3-17] vs 12.0 [IQR, 7-21] days; P = .03; Hodges-Lehmann estimate of difference, 2.92 days; 95% CI, 0.43-5.84). The reduction was mainly in effusion-related hospitalization days (median, 1.0 [IQR, 1-3] day with the indwelling pleural catheter vs 4.0 (IQR, 3-6) days with pleurodesis; P < .001; Hodges-Lehmann estimate, 2.06 days; 95% CI, 1.53-2.58). Fewer patients randomized to indwelling pleural catheter required further ipsilateral invasive pleural drainages (4.1% vs 22.5%; difference, 18.4%; 95% CI, 7.7%-29.2%). There were no significant differences in improvements in breathlessness or quality of life offered by indwelling pleural catheter or talc pleurodesis. Adverse events were seen in 22 patients in the indwelling pleural catheter group (30 events) and 13 patients in the pleurodesis group (18 events). Conclusions and Relevance: Among patients with malignant pleural effusion, treatment with an indwelling pleural catheter vs talc pleurodesis resulted in fewer hospitalization days from treatment to death, but the magnitude of the difference is of uncertain clinical importance. These findings may help inform patient choice of management for pleural effusion. Trial Registration: anzctr.org.au Identifier: ACTRN12611000567921.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
Roberts, M. E., Neville, E., Berrisford, R. G., Antunes, G., Ali, N. J., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136994 · Cited by 885
Davies, H. E., Mishra, E. K., Kahan, B. C., Wrightson, J. M., Stanton, A. E., Guhan, A., Davies, C. W. H., Grayez, J., Harrison, R., Prasad, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.5535 · Cited by 657
Self-citationHandbook of Disease Burdens and Quality of Life Measures
(2010) · Springer eBooks · doi:10.1007/978-0-387-78665-0 · Cited by 644
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion
Dresler, C. M., Olak, J., Herndon, J. E., Richards, W. G., Scalzetti, E., Fleishman, S. B., Kernstine, K. H., Demmy, T., Jablons, D. M., Kohman, L., et al. (2005) · Chest · doi:10.1378/chest.127.3.909 · Cited by 578
Management of Malignant Pleural Effusions
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.ats8-00 · Cited by 498
Clive, A. O., Kahan, B. C., Hooper, C. E., Bhatnagar, R., Morley, A. J., Zahan-Evans, N., Bintcliffe, O. J., Boshuizen, R. C., Fysh, E. T. H., Tobin, C. L., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205285 · Cited by 446
Self-citationVan Meter, M. E. M., McKee, K. Y., & Kohlwes, R. J. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1472-0 · Cited by 287
(2016) · CRC Press eBooks · doi:10.1201/b19146 · Cited by 249
Rahman, N. M., Pepperell, J., Rehal, S., Saba, T., Tang, A., Ali, N., West, A., Hettiarachchi, G., Mukherjee, D., Samuel, J., et al. (2015) · JAMA · doi:10.1001/jama.2015.16840 · Cited by 230
Self-citationThoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion
Yim, A. P. C., Chan, A. T. C., Tak, W. L., Wan, I. Y. P., & Ho, J. K. S. (1996) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)00808-9 · Cited by 219
Indwelling Pleural Catheters Reduce Inpatient Days Over Pleurodesis for Malignant Pleural Effusion
Fysh, E. T. H., Waterer, G. W., Kendall, P. A., Bremner, P. R., Dina, S., Geelhoed, E., McCarney, K., Morey, S., Millward, M., Musk, A. W. (., et al. (2012) · Chest · doi:10.1378/chest.11-2657 · Cited by 166
Self-citationThe EQ-5D Health-Related Quality of Life Questionnaire
Gusi, N., Olivares, P. R., & Rajendram, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_5 · Cited by 156
Mishra, E. K., Corcoran, J. P., Hallifax, R., Stradling, J. R., Maskell, N. A., & Rahman, N. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123798 · Cited by 136
Complications of indwelling pleural catheter use and their management
Lui, M. M., Thomas, R., & Lee, G. (2016) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2015-000123 · Cited by 117
Self-citationUse of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis
Tremblay, A., Mason, C., & Michaud, G. T. (2007) · European Respiratory Journal · doi:10.1183/09031936.00164706 · Cited by 115
Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)
Demmy, T. L., Gu, L., Burkhalter, J. E., Toloza, E. M., D’Amico, T. A., Sutherland, S., Wang, X., Archer, L. E., Veit, L. J., Kohman, L. J., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0102 · Cited by 108
Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions
Bielsa, S., Hernández, P., Rodríguez‐Panadero, F., et al. (2011) · Lung · doi:10.1007/s00408-011-9283-6 · Cited by 65
Bhatnagar, R., Kahan, B. C., Morley, A. J., Keenan, E. K., Miller, R. F., Rahman, N. M., & Maskell, N. A. (2015) · Trials · doi:10.1186/s13063-015-0563-y · Cited by 55
Fysh, E. T. H., Bielsa, S., Budgeon, C. A., Read, C., Porcel, J. M., Maskell, N. A., & Lee, G. (2014) · CHEST Journal · doi:10.1378/chest.14-1701 · Cited by 43
Self-citationThe incidence of malignant mesothelioma in Australia, 1947‐1980
Musk, A. W., Dolin, P., Armstrong, B. K., Ford, J. M., de Klerk, N. H., & HOBBS, M. S. T. (1989) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1989.tb136455.x · Cited by 39
Azzopardi, M., Thomas, R., Muruganandan, S., Lam, D. C.-L., Garske, L. A., Kwan, B. C. H., Ali, M. R. S. R., Nguyen, P., Yap, E., Horwood, F., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011480 · Cited by 36
Self-citationTreatment Options for Malignant Pleural Effusions: Patient Preference Does Matter
Maskell, N. A. (2012) · JAMA · doi:10.1001/jama.2012.5543 · Cited by 32
Fysh, E. T. H., Thomas, R., Read, C., Lam, B. C. H., Yap, E., Horwood, F., Lee, P., Piccolo, F., Shrestha, R. L., Garske, L. A., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006757 · Cited by 28
Self-citationBoshuizen, R. C., Onderwater, S., Burgers, S. J. A., & van den Heuvel, M. M. (2013) · Respiration · doi:10.1159/000351796 · Cited by 20
Cited by
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline
Feller-Kopman, D. J., Reddy, C. B., DeCamp, M. M., Diekemper, R. L., Gould, M. K., Henry, T., Iyer, N. P., Lee, Y. C. G., Lewis, S. Z., Maskell, N. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1415st · Cited by 470
Self-citationERS/EACTS statement on the management of malignant pleural effusions
Bibby, A. C., Dorn, P., Psallidas, I., Porcel, J. M., Janssen, J., Froudarakis, M., Subotic, D., Astoul, P., Licht, P., Schmid, R., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00349-2018 · Cited by 316
Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion
Bhatnagar, R., Keenan, E. K., Morley, A. J., Kahan, B. C., Stanton, A. E., Haris, M., Harrison, R. N., Mustafa, R. A., Bishop, L. J., Ahmed, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716883 · Cited by 279
Self-citationUpdate on biology and management of mesothelioma
Asciak, R., George, V., & Rahman, N. M. (2021) · European Respiratory Review · doi:10.1183/16000617.0226-2020 · Cited by 75
Metadata
- Authors
- Thomas, R., Fysh, E. T. H., Smith, N. A., Lee, P., Kwan, B. C. H., Yap, E., Horwood, F. C., Piccolo, F., Lam, D. C. L., Garske, L. A., Shrestha, R., Kosky, C., Read, C. A., Murray, K., & Lee, Y. C. G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-11-21
- Volume
- 318
- Issue
- 19
- Pages
- 1903
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2770388669
- Cited by
- 289
- References
- 24
- FWCI
- 20.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.